CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis
dc.contributor.author | Prasse, Antje | en_US |
dc.contributor.author | Pechkovsky, Dmitri V. | en_US |
dc.contributor.author | Toews, Galen B. | en_US |
dc.contributor.author | Schäfer, Markus | en_US |
dc.contributor.author | Eggeling, Stephan | en_US |
dc.contributor.author | Ludwig, Corinna | en_US |
dc.contributor.author | Germann, Martin | en_US |
dc.contributor.author | Kollert, Florian | en_US |
dc.contributor.author | Zissel, Gernot | en_US |
dc.contributor.author | Müller-Quernheim, Joachim | en_US |
dc.date.accessioned | 2007-09-20T18:36:35Z | |
dc.date.available | 2008-09-08T14:25:14Z | en_US |
dc.date.issued | 2007-05 | en_US |
dc.identifier.citation | Prasse, Antje; Pechkovsky, Dmitri V.; Toews, Galen B.; SchÄfer, Markus; Eggeling, Stephan; Ludwig, Corinna; Germann, Martin; Kollert, Florian; Zissel, Gernot; MÜller-Quernheim, Joachim (2007)."CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis." Arthritis & Rheumatism 56(5): 1685-1693. <http://hdl.handle.net/2027.42/56037> | en_US |
dc.identifier.issn | 0004-3591 | en_US |
dc.identifier.issn | 1529-0131 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/56037 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17469163&dopt=citation | en_US |
dc.description.abstract | Objective In diffuse parenchymal lung diseases, the evolution of pulmonary fibrosis is often devastating and may result in death. In this study the role of CCL18 as a biomarker of disease activity in idiopathic interstitial pneumonias (IIPs) and systemic sclerosis (SSc) with lung involvement was evaluated. Methods CCL18 was assessed in supernatants of cultured bronchoalveolar lavage (BAL) cells as well as BAL fluid and serum samples from 43 patients with IIPs, 12 patients with SSc, and 23 healthy control subjects. Concentrations of CCL18 were measured by enzyme-linked immunosorbent assay, and expression of CCL18 was assessed by flow cytometry. Results CCL18 concentrations were statistically significantly increased in all patients with fibrotic lung diseases. Spontaneous CCL18 production by BAL cells was negatively correlated with total lung capacity and the diffusion capacity for carbon monoxide, whereas there was a positive correlation of CCL18 concentrations with BAL neutrophil and eosinophil cell counts. Flow cytometry revealed an increase in the percentage of CCL18-positive alveolar macrophages and an increase in the CCL18 fluorescence intensity per cell in patients with fibrotic lung diseases. In a cohort of patients who were followed up for at least 6 months (n = 40), a close negative correlation was observed between changes in the predicted total lung capacity and changes in CCL18 serum concentrations. Conclusion These findings suggest that CCL18 production by BAL cells and serum CCL18 concentrations reflect pulmonary fibrotic activity in patients with IIPs and those with SSc. Monitoring changes in CCL18 production might be an extraordinarily useful tool in clinical practice and in studies aimed at evaluating new approaches for treatment of fibrotic lung diseases. | en_US |
dc.format.extent | 342175 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.title | CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Geriatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan Medical School, Ann Arbor | en_US |
dc.contributor.affiliationother | University Hospital Freiburg, Freiburg, Germany ; Department of Pneumology, University Hospital Freiburg, Killianstrasse 5, 79106 Freiburg, Germany | en_US |
dc.contributor.affiliationother | University Hospital Freiburg, Freiburg, Germany | en_US |
dc.contributor.affiliationother | University Hospital Freiburg, Freiburg, Germany | en_US |
dc.contributor.affiliationother | University Hospital Freiburg, Freiburg, Germany | en_US |
dc.contributor.affiliationother | University Hospital Freiburg, Freiburg, Germany | en_US |
dc.contributor.affiliationother | University Hospital Freiburg, Freiburg, Germany | en_US |
dc.contributor.affiliationother | University Hospital Freiburg, Freiburg, Germany | en_US |
dc.contributor.affiliationother | University Hospital Freiburg, Freiburg, Germany | en_US |
dc.contributor.affiliationother | University Hospital Freiburg, Freiburg, Germany | en_US |
dc.identifier.pmid | 17469163 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/56037/1/22559_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/art.22559 | en_US |
dc.identifier.source | Arthritis & Rheumatism | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.